Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Amyotrophic Lateral Sclerosis

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/17482968.2011.574142PMID 21864053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• VEGF protects motor neurons against excitotoxicity by upregulation of GluR2.

  2010cited by this paper
• Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS.

  2010cited by this paper
• An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury.

  2010cited by this paper
• AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.

  2010cited by this paper
• Vascular endothelial growth factor prevents G93A‐SOD1‐induced motor neuron degeneration

  2009cited by this paper
• Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice

  2009cited by this paper
• Engineered Zinc Finger Protein–Mediated VEGF-A Activation Restores Deficient VEGF-A in Sensory Neurons in Experimental Diabetes

  2009cited by this paper
• Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression

  2009cited by this paper
• VEGF and ALS.

  2008cited by this paper
• Vascular endothelial growth factor protects spinal cord motoneurons against glutamate‐induced excitotoxicity via phosphatidylinositol 3‐kinase

  2008cited by this paper
• Vascular Endothelial Growth Factor Overexpression Delays Neurodegeneration and Prolongs Survival in Amyotrophic Lateral Sclerosis Mice

  2007cited by this paper
• Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.

  2007cited by this paper
• Vascular endothelial growth factor counteracts the loss of phospho‐Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis

  2007cited by this paper
• Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases

  2006cited by this paper
• Expression of Vascular Endothelial Growth Factor and Its Receptors in the Central Nervous System in Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Gene‐based treatment of motor neuron diseases

  2006cited by this paper
• VEGF at the neurovascular interface: therapeutic implications for motor neuron disease.

  2006cited by this paper
• Disease progression of human SOD1 (G93A) transgenic ALS model rats

  2006cited by this paper
• Gene Transfer of an Engineered Transcription Factor Promoting Expression of VEGF-A Protects Against Experimental Diabetic Neuropathy

  2006cited by this paper
• An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.

  2006cited by this paper
• Neuroprotective Role of Vascular Endothelial Growth Factor: Signalling Mechanisms, Biological Function, and Therapeutic Potential

  2005cited by this paper
• HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy

  2005cited by this paper
• Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

  2005cited by this paper
• Unraveling the mechanisms involved in motor neuron degeneration in ALS.

  2004cited by this paper
• Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS

  2004cited by this paper
• Low levels of the vascular endothelial growth factor in CSF from early ALS patients

  2004cited by this paper
• Engineered Zinc Finger–Activating Vascular Endothelial Growth Factor Transcription Factor Plasmid DNA Induces Therapeutic Angiogenesis in Rabbits With Hindlimb Ischemia

  2004cited by this paper
• VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

  2004cited by this paper
• Drug discovery with engineered zinc-finger proteins

  2003cited by this paper
• VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

  2003cited by this paper
• Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)

  2002cited by this paper
• Neuronal survival following remote adenovirus gene delivery.

  2002cited by this paper
• Induction of angiogenesis in a mouse model using engineered transcription factors

  2002cited by this paper
• Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches

  2002cited by this paper
• Skeletal muscle fiber function and rate of disease progression in amyotrophic lateral sclerosis

  2002cited by this paper
• Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells

  2001cited by this paper
• Mobilization of Endothelial and Hematopoietic Stem and Progenitor Cells by Adenovector‐Mediated Elevation of Serum Levels of SDF‐1, VEGF, and Angiopoietin‐1

  2001cited by this paper
• Regulation of an Endogenous Locus Using a Panel of Designed Zinc Finger Proteins Targeted to Accessible Chromatin Regions

  2001cited by this paper
• Reversal of experimental diabetic neuropathy by VEGF gene transfer.

  2001cited by this paper
• Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

  2001cited by this paper
• Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia.

  2000cited by this paper
• Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk‐1 receptor

  2000cited by this paper
• Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1

  1998cited by this paper
• Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells.

  1997cited by this paper
• Inherited Neurodegenerative Diseases and Transgenic Models

  1996cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• A Sensitive and Reliable Locomotor Rating Scale for Open Field Testing in Rats

  1995cited by this paper
• Muscle morphometry in amyotrophic lateral sclerosis.

  1991cited by this paper
• Medial gastrocnemius motor nucleus in the rat: Age‐related changes in the number and size of motoneurons

  1988cited by this paper

• Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases

  2021cites this paper
• Delivery of transcription factors as modulators of cell differentiation

  2021cites this paper
• Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.

  2019cites this paper
• Gene Therapy for Amyotrophic Lateral Sclerosis

  2017cites this paper
• Intraspinal stem cell transplantation for amyotrophic lateral sclerosis

  2016cites this paper
• The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis

  2016cites this paper
• Vascular endothelial growth factor: a neurovascular target in neurological diseases

  2016cites this paper
• Trophic Factors in the Therapeutic Challenge Against ALS: Current Research Directions

  2016cites this paper
• Nanotechnology-based drug-delivery systems releasing growth factors to the CNS: Focusing on neurodegenerative disorders

  2016cites this paper
• Integration of drug, protein, and gene delivery systems with regenerative medicine

  2015cites this paper
• Gene therapy for neurodegenerative diseases.

  2015cites this paper
• Synthetic biology and therapeutic strategies for the degenerating brain

  2014cites this paper
• Gene and protein therapies utilizing VEGF for ALS.

  2014cites this paper
• Roles of Vascular Endothelial Growth Factor in Amyotrophic Lateral Sclerosis

  2014cites this paper
• Recent Advances in ALS Research: Perspectives for Personalized Clinical Application

  2013cites this paper
• Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model.

  2013cites this paper
• ALS and Oxidative Stress: The Neurovascular Scenario

  2013cites this paper
• VEGF Improves Skeletal Muscle Regeneration After Acute Trauma and Reconstruction of the Limb in a Rabbit Model

  2012cites this paper